Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H6N2 |
Molecular Weight | 82.1038 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NNC=C1
InChI
InChIKey=XKVUYEYANWFIJX-UHFFFAOYSA-N
InChI=1S/C4H6N2/c1-4-2-3-5-6-4/h2-3H,1H3,(H,5,6)
Molecular Formula | C4H6N2 |
Molecular Weight | 82.1038 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Characterization of enzymes responsible for biotransformation of the new antileukotrienic drug quinlukast in rat liver microsomes and in primary cultures of rat hepatocytes. | 2004 Feb |
|
From model compounds to protein binding: syntheses, characterizations and fluorescence studies of [RuII(bipy)(terpy)L]2+ complexes (bipy = 2,2'-bipyridine; terpy = 2,2':6',2''-terpyridine; L = imidazole, pyrazole and derivatives, cytochrome c). | 2005 Jan 21 |
|
Formation of 4'-carboxyl acid metabolite of imrecoxib by rat liver microsomes. | 2006 Apr |
|
Methylpyrazole-capped two-dimensional supramolecular M(II) (M = Mn, Ni, Co) assemblies constructed by covalent and noncovalent interactions: uncommon coordination modes of methylpyrazoles and magnetic properties. | 2006 Jul 24 |
|
Pyrazole and methylpyrazole for the treatment of 2-butoxyethanol poisoning. | 2007 Jan-Feb |
|
An improved methyltrioxorhenium-catalyzed epoxidation of alkenes with hydrogen peroxide. | 2007 Jul 7 |
|
Scaffold hopping, synthesis and structure-activity relationships of 5,6-diaryl-pyrazine-2-amide derivatives: a novel series of CB1 receptor antagonists. | 2007 Jun 15 |
|
Biotransformation and pharmacokinetics of the novel anticancer drug, SYUIQ-5, in the rat. | 2008 Apr |
|
A novel tripodal ligand containing three different N-heterocyclic donor functions and its application in catechol dioxygenase mimicking. | 2009 |
|
The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro. | 2010 Dec 1 |
|
Gateways to clinical trials. | 2010 May |
|
An effective procedure for the synthesis of acid-sensitive epoxides: use of 1-methylimidazole as the additive on methyltrioxorhenium-catalyzed epoxidation of alkenes with hydrogen peroxide. | 2010 May 21 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:35:59 GMT 2023
by
admin
on
Fri Dec 15 19:35:59 GMT 2023
|
Record UNII |
W7KU1RRO6U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
215-925-7
Created by
admin on Fri Dec 15 19:35:59 GMT 2023 , Edited by admin on Fri Dec 15 19:35:59 GMT 2023
|
PRIMARY | |||
|
W7KU1RRO6U
Created by
admin on Fri Dec 15 19:35:59 GMT 2023 , Edited by admin on Fri Dec 15 19:35:59 GMT 2023
|
PRIMARY | |||
|
1453-58-3
Created by
admin on Fri Dec 15 19:35:59 GMT 2023 , Edited by admin on Fri Dec 15 19:35:59 GMT 2023
|
PRIMARY | |||
|
15073
Created by
admin on Fri Dec 15 19:35:59 GMT 2023 , Edited by admin on Fri Dec 15 19:35:59 GMT 2023
|
PRIMARY | |||
|
DTXSID3073260
Created by
admin on Fri Dec 15 19:35:59 GMT 2023 , Edited by admin on Fri Dec 15 19:35:59 GMT 2023
|
PRIMARY |